Neurodevelopmental Outcomes after Pediatric Cardiac ECMO Support

Constantinos Chrysostomou1, Timothy Maul2, Patrick M Callahan3

  • 1Critical Care Medicine, Cardiac Intensive Care, Children's Hospital of Pittsburgh of UPMC , Pittsburgh, PA , USA.

Frontiers in Pediatrics
|January 9, 2014
PubMed

Insights

Pediatric cardiac extracorporeal membrane oxygenation (ECMO) offers good survival rates and neurodevelopmental outcomes. Most survivors experience mild disability, with many showing neurologic improvement over time.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Intensive Care
  • Neurodevelopmental Outcomes

Background:

  • Cardiac extracorporeal membrane oxygenation (ECMO) is a critical intervention for critically ill pediatric patients with cardiac disease.
  • Understanding the long-term neurodevelopmental impact of ECMO is crucial for optimizing patient care.

Purpose of the Study:

  • To characterize neurodevelopmental outcomes in pediatric cardiac ECMO patients.
  • To identify factors associated with adverse neurodevelopmental outcomes.

Main Methods:

  • A five-year retrospective review of pediatric cardiac ECMO patients.
  • Analysis included demographics, cardiac lesion, surgical complexity, ECMO details, and complications.
  • Neurodevelopmental status assessed using Pediatric Overall Performance Category and Pediatric Cerebral Performance Category Scales.

Main Results:

  • Overall ECMO survival was 73% at discharge and 66% at follow-up.
  • Moderate to severe disability at discharge linked to CPR, plasma exchange, or intracranial insults.
  • Cerebral infarction was the sole predictor of neurological deterioration at later follow-up.

Conclusions:

  • Pediatric cardiac ECMO demonstrates favorable short- and long-term survival rates.
  • Most survivors exhibit normal to mild neurodevelopmental disability, with significant improvement noted.
  • Comprehensive neuropsychological testing is essential for all pediatric ECMO survivors.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790